Remedy Meds tirzepatide review
$4,788 a year, all in. That is $3,288 more than the cheapest option. Flat pricing with unlimited clinician access.
Recorded article date: 2026-09-18
This article retains historical comparison material. Its record date is not a current offer check. Selected newer reviews have their own dates and limits; consult those reviews and the applicable written terms before comparing a purchase.
$399 a month, about $4,788 a year — flat at every dose, which is the right structure at roughly triple the cheapest price for it.
The first month is discounted to $279 and renews at $399. Medication is included in the fee rather than billed separately, and unlimited clinician access comes with it.
The yearly bill
| Remedy Meds · tirzepatide | |
|---|---|
| Advertised from | $279/mo |
| Membership on top | None |
| What you actually pay | $399/mo |
| Over twelve months | $4,788 |
| Versus the cheapest option | +$3,288 a year |
| Cheapest-first position | 18 of 20 |
The $279 is a first-month rate; it renews at $399. Flat across every dose, which benefits anyone titrating high.
Where the money goes
Flat dose pricing is genuinely valuable: your bill does not climb as the treatment starts working. Remedy Meds also sells branded Zepbound at around $1,399 a month, which puts the compounded figure in context.
Compounded GLP-1 programme with two flat monthly prices that do not change with dose, medication included in the monthly fee.
What the same money buys elsewhere
Almost everything. Trimi at about $1,500 saves roughly $3,288 a year; Coreage Rx month-to-month saves about $2,400; even mid-market Zealthy saves $2,196.
| Programme | Recorded monthly figure | Recorded figure × 12 | Difference from stored minimum × 12 | Record date |
|---|---|---|---|---|
| Coreage Rx Paid first placement Recorded membership: $0 | $199 | $2,388 | +$888 | 2026-10-04 |
| SuperHealthy Rx Publisher-selected placement Recorded membership: $0 | $135 | $1,620 | +$120 | 2026-10-04 |
| Likeness Rx Publisher-selected placement Recorded membership: $0 | $199 | $2,388 | +$888 | 2026-10-04 |
| Trimi Recorded membership: $0 | $125 | $1,500 | — | 2026-09-18 |
| Ozari Health Recorded membership: $0 | $125 | $1,500 | — | 2026-09-18 |
| Fifty 410 Recorded membership: $0 | $133 | $1,596 | +$96 | 2026-09-18 |
Is the extra worth it?
Unlimited clinician access is worth real money, but Ivím offers it at $199. We cannot construct the case for paying double that for the same feature.
What we checked
- Compounded semaglutide priced at $299/month flat, regardless of dose.
- Compounded tirzepatide priced at $399/month flat, regardless of dose.
- First month of tirzepatide discounted to $279, then $399/month.
- Medication is included in the monthly fee rather than billed separately.
- Unlimited clinician access, check-ins and dose adjustments included.
- Branded Zepbound offered at around $1,399/month.
Verified 2026-09-18. Prices in this market move, so treat anything older than a month as a starting point rather than a quote.
The good
- Genuinely flat pricing — the dose can go to the top of the ladder without the bill moving.
- Unlimited clinician access is included rather than sold as an upgrade.
- Medication is inside the monthly fee, so there is no second bill.
The bad
- Expensive relative to the flat-rate leaders for the same class of medication.
- The $279 first month steps up to $399 on renewal.
Watch for this at checkout. The $279 introductory tirzepatide month renews at $399. Budget from the renewal figure.
Verdict
Right structure, wrong number. Several programmes here offer flat dose pricing for half as much.
Full workings for every programme are in the cheapest tirzepatide programmes, and our scoring is explained on how we rate.
Read next
CoreAge Rx pays us a commission on sign-ups through our links and pays for the first position in our price tables where included. How we rate · Disclosure